Skip to main content
  • About
  • Careers
  • Locations
ArentFox Schiff

Main navigation

  • Attorneys
  • Industries & Practices
  • Insights
Search the Site Search the Site
Toggle Main Menu

Main navigation

  • Attorneys
  • Industries & Practices
  • Insights
    • Blogs
    • Alerts
    • Events
    • News
    • The Fine Print
    • Fashion Counsel
    • Press Releases
    • Health Care Counsel Blog
    • Managing Automotive Blog
    • AI Law Blog
    • Longevity Lens
    • Trade Secrets Case Watch
    • Trump’s Policy Playbook
    • Consumer Products Watch
    • Customs & Import Compliance Blog
    • Environmental Law Advisor
    • Energy & Cleantech Counsel
    • The In-House Advisor
    • International Arbitration & Dispute Resolution Blog
    • Investigations Blog
    • National Security Counsel
    • Privacy Counsel

Footer

  • About
    • Leadership
    • Alumni
    • Diversity
    • Pro Bono
  • Careers
    • Attorney Opportunities
    • Professional Opportunities
    • Summer Program
  • Locations
    • Washington, DC
    • Chicago
    • New York
    • Los Angeles
    • Boston
    • San Francisco
    • Lake Forest
    • Ann Arbor
    • Decentraland
  • Contact
    • Client Payments
    • Subscribe

Search

Breadcrumb

  1. Insights
Longevity & Healthspan

Longevity Lens

A Look Inside the Innovation Powering Better Health for Longer

News

Competing Biomarker Providers Clash: Function Health Sues Superpower Health Over Allegedly Deceptive Advertisements
March 10, 2026
Gayland O. Hethcoat II, Jared Ahmed
ARPA-H Emerges as Top Longevity Agency Amid Funding and Staffing Fluctuations
February 13, 2026
Starshine S. Chun*, Gayland O. Hethcoat II, Blake K. Thelander*
The Eyes Have It: FDA Approves Phase 1 Clinical Trial of Life Biosciences’ Reprogramming Therapy for Vision Loss
February 5, 2026
Abha Kundi*, Gayland O. Hethcoat II, Shoshana Golden
Lupo and Hethcoat Quoted on ArentFox Schiff Launch of Longevity & Healthspan Industry Group
January 28, 2026
Anthony V. Lupo, Gayland O. Hethcoat II

Featured

The Regulatory Roadmap: Five Critical Questions for Evaluating Regulatory Risk for Longevity Companies
February 10, 2026
Gayland O. Hethcoat II, Abha Kundi*, Michelle R. Bowling

The longevity ecosystem sits at the crossroads of health care, life sciences, consumer wellness, artificial intelligence (AI), and other emerging technologies.

Search or View All Longevity Lens Content

Core Team
Karen Ellis Carr Portrait
Karen Ellis Carr

Partner and FDA Practice Leader

Contact Me
Gayland Hethcoat Portrait
Gayland O. Hethcoat II
Counsel
Contact Me
Abha Kundi Portrait
Abha Kundi*
Counsel
Contact Me
Jo-Ann Marchica Portrait
Jo-Ann Marchica
Partner
Contact Me
Marc Rivera Portrait
Marc E. Rivera
Partner
Contact Me
Michael Scarpati, Ph.D. Portrait
Michael Scarpati, Ph.D.

Partner and AI & Emerging Technologies Industry Group Co-Leader

Contact Me
Jill Steinberg Portrait
Jill A. Steinberg
Partner
Contact Me

Footer

  • About
    • Leadership
    • Alumni
    • Diversity
    • Pro Bono
  • Careers
    • Attorney Opportunities
    • Professional Opportunities
    • Summer Program
  • Locations
    • Washington, DC
    • Chicago
    • New York
    • Los Angeles
    • Boston
    • San Francisco
    • Lake Forest
    • Ann Arbor
    • Decentraland
  • Contact
    • Client Payments
    • Subscribe

Social

Linkedin Twitter Youtube

Sub footer

  • Disclaimer
  • Privacy Policy
  • Terms of Use
  • Accessibility
  • Non Discrimination

© Copyright 2026 ArentFox Schiff LLP. All Rights Reserved.

Back to Top